VCG
EGRX

Vantage Consulting Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Vantage Consulting Group’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-485
Closed -$23K – 1667
2020
Q4 		$23K Buy
+485
New +$23K ﹤0.01% 825